Clinical Trial Update: Investigating the Efficacy of Ergothioneine to Delay Cognitive Decline (Pilot) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a completed Phase 1/2 pilot study evaluating whether ergothioneine can delay cognitive decline in people with mild cogniti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Ergothioneine (Ergothioneine)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Mild Cognitive Impairment | Phase 1, Phase 2 | Status: COMPLETED